Moroccan medical technology company T2S Group has completed a $120 million initial public offering (IPO) on the Casablanca Stock Exchange, achieving a $520 million valuation after...
When the COVID-19 pandemic exposed how dependent the Middle East and Africa had become on imported diagnostic kits, Egyptian nanomedicine researcher Dr. Salma Tammam realized the...
Series A funding will support clinical advancement of oral therapies for male infertility and adenomyosis
The B2B pharmaceutical supply platform lands ethical, non-dilutive capital from Bokra to scale digital operations across Egypt